2024 | 2023 | |||||||
| Underlying | Underlying | |||||||
| business | Non-trading | business | Non-trading | |||||
| performance | items | Total | performance | items | Total | |||
| Note | US$m | US$m | US$m | US$m | US$m | US$m | ||
Revenue | 2 | |||||||
Cost of sales | ( | ( | ( | ( | ||||
Gross profit | ||||||||
Selling and distribution costs | ( | ( | ( | ( | ||||
Administration expenses | ( | ( | ( | ( | ||||
Other operating (expense)/income | ( | ( | ( | |||||
| Change in fair value of | ||||||||
investment properties | 12 | ( | ( | ( | ( | |||
| Net gain on sale of | ||||||||
subsidiaries and asset disposals | 8 | |||||||
Operating (loss)/profit | 3 | ( | ( | ( | ( | |||
Financing charges | ( | ( | ( | ( | ( | |||
Interest income | ||||||||
Net financing charges | 4 | ( | ( | ( | ( | |||
| Share of results of associates | ||||||||
and joint ventures | 5 | ( | ( | ( | ( | |||
(Loss)/profit before tax | ( | ( | ( | ( | ||||
Tax | 6 | ( | ( | ( | ( | ( | ( | |
(Loss)/profit after tax | ( | ( | ( | ( | ||||
| Attributable to: | ||||||||
Shareholders of the Company | 7&8 | ( | ( | ( | ( | |||
Non-controlling interests | ||||||||
( | ( | ( | ( | |||||
US¢ | US¢ | US¢ | US¢ | |||||
(Loss)/earnings per share | 7 | |||||||
– basic and diluted | ( | ( | ||||||
40 | Mandarin Oriental International Limited |
| 2024 | 2023 | ||
| US$m | US$m | ||
Loss for the year | ( | ( | |
| Other comprehensive expense | |||
| Items that will not be reclassified to profit or loss: | |||
Remeasurements of defined benefit plans | 16 | ( | ( |
Tax on items that will not be reclassified | 6 | ||
( | ( | ||
| Items that may be reclassified subsequently to profit or loss: | |||
| Net exchange translation differences | |||
– net (loss)/gain arising during the year | ( | ||
– transfer to profit and loss | |||
| Cash flow hedges | |||
– net loss arising during the year | ( | ( | |
Tax relating to items that may be reclassified | 6 | ||
Share of other comprehensive (expense)/income of associates and joint ventures | ( | ||
Other comprehensive income for the year, net of tax | |||
Total comprehensive expense for the year | ( | ( | |
| Attributable to: | |||
Shareholders of the Company | ( | ( | |
Non-controlling interests | ( | ||
( | ( |
| 2024 | 2023 | ||
| US$m | US$m | ||
| Net assets | |||
Intangible assets | 9 | ||
Tangible assets | 10 | ||
Right-of-use assets | 11 | ||
Investment properties | 12 | ||
Associates and joint ventures | 13 | ||
Other investments | 14 | ||
Deferred tax assets | 15 | ||
Pension assets | 16 | ||
Non-current debtors | 17 | ||
Non-current assets | |||
Stocks | |||
Current debtors | 17 | ||
Current tax assets | |||
Cash and bank balances | 18 | ||
Assets classified as held for sale | 19 | ||
Current assets | |||
Current creditors | 20 | ( | ( |
Current borrowings | 21 | ( | ( |
Current lease liabilities | 22 | ( | ( |
Current tax liabilities | ( | ( | |
( | ( | ||
Liabilities directly associated with assets classified as held for sale | 19 | ( | |
Current liabilities | ( | ( | |
Net current assets/(liabilities) | ( | ||
Long-term borrowings | 21 | ( | ( |
Non-current lease liabilities | 22 | ( | ( |
Deferred tax liabilities | 15 | ( | ( |
Pension liabilities | 16 | ( | |
Non-current creditors | 20 | ( | ( |
Non-current liabilities | ( | ( | |
| Total equity | |||
Share capital | 24 | ||
Share premium | 25 | ||
Revenue and other reserves | |||
Shareholders’ funds | |||
Non-controlling interests | |||
| Asset | Attributable to | Attributable to | Total | |||||||
| Share | Share | Capital | Revenue | revaluation | Hedging | Exchange | shareholders of | non-controlling | equity | |
| capital | premium | reserves | reserves | reserves | reserves | reserves | the Company | interests | ||
| US$m | US$m | US$m | US$m | US$m | US$m | US$m | US$m | US$m | US$m | |
| 2024 | ||||||||||
At 1 January | ( | ( | ||||||||
Total comprehensive income | ( | ( | ( | ( | ( | |||||
Dividends paid by the Company | ( | ( | ( | |||||||
At 31 December | ( | ( | ( | |||||||
| 2023 | ||||||||||
At 1 January | ( | ( | ||||||||
Total comprehensive income | ( | ( | ( | ( | ||||||
Dividends paid by the Company | ( | ( | ( | |||||||
| Unclaimed dividend | ||||||||||
| forfeited | ||||||||||
| Subsidiary | ||||||||||
| disposed of | ( | ( | ( | |||||||
Transfer | ( | |||||||||
At 31 December | ( | ( | ||||||||
Revenue reserves as at 31 December 2024 included cumulative fair value losses on the investment property under development of US$1,378.8 million (2023: US$1,207.8 million). |
| 2024 | 2023 | ||
| US$m | US$m | ||
| Operating activities | |||
Operating loss | 3 | ( | ( |
Depreciation, amortisation and impairment | |||
Other non-cash items | 28a | ||
Movements in working capital | 28b | ( | ( |
Interest received | |||
Interest and other financing charges paid | ( | ( | |
Tax paid for underlying business performance | ( | ( | |
Tax paid for sale of subsidiaries and asset disposals | ( | ( | |
Total tax paid | ( | ( | |
Dividends and interest from associates and joint ventures | |||
Cash flows from operating activities | |||
| Investing activities | |||
Purchase of tangible assets | ( | ( | |
Additions to investment properties | ( | ( | |
Purchase of intangible assets | ( | ( | |
Purchase of Mandarin Oriental Exceptional Homes business | 28c | ( | |
Purchase of other investments | ( | ( | |
Advance to associates and joint ventures | 28d | ( | |
Repayment of loans to associates and joint ventures | 28e | ||
Sale of subsidiaries | 28f | ||
Net proceeds from asset disposals | 19 | ||
Cash flows from investing activities | |||
| Financing activities | |||
Drawdown of borrowings | 21 | ||
Repayment of borrowings | 21 | ( | ( |
Principal elements of lease payments | 28g | ( | ( |
Dividends paid by the Company | 26 | ( | ( |
Cash flows from financing activities | ( | ( | |
Net increase/(decrease) in cash and cash equivalents | ( | ||
Cash and cash equivalents at 1 January | |||
Effect of exchange rate changes | ( | ||
Cash and cash equivalents at 31 December | 28h |